English
简体中文
Total: £ 56.28
Published Date: 2025-06-30 | Pages: 88 | Tables: 90 | Medical Care
The global market for Crispr Genomic Cure was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Crispr Genomic Cure is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Crispr Genomic Cure is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Crispr Genomic Cure in Biomedical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Crispr Genomic Cure include Abcam, Applied StemCel, Beam Therapeutics, CALYXT, Cellecta, Cellectis, CRISPR Therapeutics AG, Editas Medicine, ERS Genomics, Integrated DNA Technologies, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Crispr Genomic Cure, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crispr Genomic Cure.
The Crispr Genomic Cure market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Crispr Genomic Cure market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crispr Genomic Cure companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
Applied StemCel
Beam Therapeutics
CALYXT
Cellecta
Cellectis
CRISPR Therapeutics AG
Editas Medicine
ERS Genomics
Integrated DNA Technologies
Intellia Therapeutics
Merck KGaA
New England Biolabs
Precision BioSciences
Sangamo Therapeutics
Segment by Type
gRNA Design and Vector Construction
Cell Line and Engineering
Others
Segment by Application
Biomedical
Pharmaceutical
Agricultural
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crispr Genomic Cure company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Crispr Genomic Cure Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 gRNA Design and Vector Construction
1.2.3 Cell Line and Engineering
1.2.4 Others
1.3 Market by Application
1.3.1 Global Crispr Genomic Cure Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biomedical
1.3.3 Pharmaceutical
1.3.4 Agricultural
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Crispr Genomic Cure Market Perspective (2020-2031)
2.2 Global Crispr Genomic Cure Growth Trends by Region
2.2.1 Global Crispr Genomic Cure Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Crispr Genomic Cure Historic Market Size by Region (2020-2025)
2.2.3 Crispr Genomic Cure Forecasted Market Size by Region (2026-2031)
2.3 Crispr Genomic Cure Market Dynamics
2.3.1 Crispr Genomic Cure Industry Trends
2.3.2 Crispr Genomic Cure Market Drivers
2.3.3 Crispr Genomic Cure Market Challenges
2.3.4 Crispr Genomic Cure Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Crispr Genomic Cure Players by Revenue
3.1.1 Global Top Crispr Genomic Cure Players by Revenue (2020-2025)
3.1.2 Global Crispr Genomic Cure Revenue Market Share by Players (2020-2025)
3.2 Global Crispr Genomic Cure Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Crispr Genomic Cure Revenue
3.4 Global Crispr Genomic Cure Market Concentration Ratio
3.4.1 Global Crispr Genomic Cure Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Crispr Genomic Cure Revenue in 2024
3.5 Global Key Players of Crispr Genomic Cure Head office and Area Served
3.6 Global Key Players of Crispr Genomic Cure, Product and Application
3.7 Global Key Players of Crispr Genomic Cure, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Crispr Genomic Cure Breakdown Data by Type
4.1 Global Crispr Genomic Cure Historic Market Size by Type (2020-2025)
4.2 Global Crispr Genomic Cure Forecasted Market Size by Type (2026-2031)
5 Crispr Genomic Cure Breakdown Data by Application
5.1 Global Crispr Genomic Cure Historic Market Size by Application (2020-2025)
5.2 Global Crispr Genomic Cure Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Crispr Genomic Cure Market Size (2020-2031)
6.2 North America Crispr Genomic Cure Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Crispr Genomic Cure Market Size by Country (2020-2025)
6.4 North America Crispr Genomic Cure Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Crispr Genomic Cure Market Size (2020-2031)
7.2 Europe Crispr Genomic Cure Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Crispr Genomic Cure Market Size by Country (2020-2025)
7.4 Europe Crispr Genomic Cure Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Crispr Genomic Cure Market Size (2020-2031)
8.2 Asia-Pacific Crispr Genomic Cure Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Crispr Genomic Cure Market Size by Region (2020-2025)
8.4 Asia-Pacific Crispr Genomic Cure Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Crispr Genomic Cure Market Size (2020-2031)
9.2 Latin America Crispr Genomic Cure Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Crispr Genomic Cure Market Size by Country (2020-2025)
9.4 Latin America Crispr Genomic Cure Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Crispr Genomic Cure Market Size (2020-2031)
10.2 Middle East & Africa Crispr Genomic Cure Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Crispr Genomic Cure Market Size by Country (2020-2025)
10.4 Middle East & Africa Crispr Genomic Cure Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam Crispr Genomic Cure Introduction
11.1.4 Abcam Revenue in Crispr Genomic Cure Business (2020-2025)
11.1.5 Abcam Recent Development
11.2 Applied StemCel
11.2.1 Applied StemCel Company Details
11.2.2 Applied StemCel Business Overview
11.2.3 Applied StemCel Crispr Genomic Cure Introduction
11.2.4 Applied StemCel Revenue in Crispr Genomic Cure Business (2020-2025)
11.2.5 Applied StemCel Recent Development
11.3 Beam Therapeutics
11.3.1 Beam Therapeutics Company Details
11.3.2 Beam Therapeutics Business Overview
11.3.3 Beam Therapeutics Crispr Genomic Cure Introduction
11.3.4 Beam Therapeutics Revenue in Crispr Genomic Cure Business (2020-2025)
11.3.5 Beam Therapeutics Recent Development
11.4 CALYXT
11.4.1 CALYXT Company Details
11.4.2 CALYXT Business Overview
11.4.3 CALYXT Crispr Genomic Cure Introduction
11.4.4 CALYXT Revenue in Crispr Genomic Cure Business (2020-2025)
11.4.5 CALYXT Recent Development
11.5 Cellecta
11.5.1 Cellecta Company Details
11.5.2 Cellecta Business Overview
11.5.3 Cellecta Crispr Genomic Cure Introduction
11.5.4 Cellecta Revenue in Crispr Genomic Cure Business (2020-2025)
11.5.5 Cellecta Recent Development
11.6 Cellectis
11.6.1 Cellectis Company Details
11.6.2 Cellectis Business Overview
11.6.3 Cellectis Crispr Genomic Cure Introduction
11.6.4 Cellectis Revenue in Crispr Genomic Cure Business (2020-2025)
11.6.5 Cellectis Recent Development
11.7 CRISPR Therapeutics AG
11.7.1 CRISPR Therapeutics AG Company Details
11.7.2 CRISPR Therapeutics AG Business Overview
11.7.3 CRISPR Therapeutics AG Crispr Genomic Cure Introduction
11.7.4 CRISPR Therapeutics AG Revenue in Crispr Genomic Cure Business (2020-2025)
11.7.5 CRISPR Therapeutics AG Recent Development
11.8 Editas Medicine
11.8.1 Editas Medicine Company Details
11.8.2 Editas Medicine Business Overview
11.8.3 Editas Medicine Crispr Genomic Cure Introduction
11.8.4 Editas Medicine Revenue in Crispr Genomic Cure Business (2020-2025)
11.8.5 Editas Medicine Recent Development
11.9 ERS Genomics
11.9.1 ERS Genomics Company Details
11.9.2 ERS Genomics Business Overview
11.9.3 ERS Genomics Crispr Genomic Cure Introduction
11.9.4 ERS Genomics Revenue in Crispr Genomic Cure Business (2020-2025)
11.9.5 ERS Genomics Recent Development
11.10 Integrated DNA Technologies
11.10.1 Integrated DNA Technologies Company Details
11.10.2 Integrated DNA Technologies Business Overview
11.10.3 Integrated DNA Technologies Crispr Genomic Cure Introduction
11.10.4 Integrated DNA Technologies Revenue in Crispr Genomic Cure Business (2020-2025)
11.10.5 Integrated DNA Technologies Recent Development
11.11 Intellia Therapeutics
11.11.1 Intellia Therapeutics Company Details
11.11.2 Intellia Therapeutics Business Overview
11.11.3 Intellia Therapeutics Crispr Genomic Cure Introduction
11.11.4 Intellia Therapeutics Revenue in Crispr Genomic Cure Business (2020-2025)
11.11.5 Intellia Therapeutics Recent Development
11.12 Merck KGaA
11.12.1 Merck KGaA Company Details
11.12.2 Merck KGaA Business Overview
11.12.3 Merck KGaA Crispr Genomic Cure Introduction
11.12.4 Merck KGaA Revenue in Crispr Genomic Cure Business (2020-2025)
11.12.5 Merck KGaA Recent Development
11.13 New England Biolabs
11.13.1 New England Biolabs Company Details
11.13.2 New England Biolabs Business Overview
11.13.3 New England Biolabs Crispr Genomic Cure Introduction
11.13.4 New England Biolabs Revenue in Crispr Genomic Cure Business (2020-2025)
11.13.5 New England Biolabs Recent Development
11.14 Precision BioSciences
11.14.1 Precision BioSciences Company Details
11.14.2 Precision BioSciences Business Overview
11.14.3 Precision BioSciences Crispr Genomic Cure Introduction
11.14.4 Precision BioSciences Revenue in Crispr Genomic Cure Business (2020-2025)
11.14.5 Precision BioSciences Recent Development
11.15 Sangamo Therapeutics
11.15.1 Sangamo Therapeutics Company Details
11.15.2 Sangamo Therapeutics Business Overview
11.15.3 Sangamo Therapeutics Crispr Genomic Cure Introduction
11.15.4 Sangamo Therapeutics Revenue in Crispr Genomic Cure Business (2020-2025)
11.15.5 Sangamo Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Crispr Genomic Cure Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of gRNA Design and Vector Construction
Table 3. Key Players of Cell Line and Engineering
Table 4. Key Players of Others
Table 5. Global Crispr Genomic Cure Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Crispr Genomic Cure Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Crispr Genomic Cure Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Crispr Genomic Cure Market Share by Region (2020-2025)
Table 9. Global Crispr Genomic Cure Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Crispr Genomic Cure Market Share by Region (2026-2031)
Table 11. Crispr Genomic Cure Market Trends
Table 12. Crispr Genomic Cure Market Drivers
Table 13. Crispr Genomic Cure Market Challenges
Table 14. Crispr Genomic Cure Market Restraints
Table 15. Global Crispr Genomic Cure Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Crispr Genomic Cure Market Share by Players (2020-2025)
Table 17. Global Top Crispr Genomic Cure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crispr Genomic Cure as of 2024)
Table 18. Ranking of Global Top Crispr Genomic Cure Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Crispr Genomic Cure Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Crispr Genomic Cure, Headquarters and Area Served
Table 21. Global Key Players of Crispr Genomic Cure, Product and Application
Table 22. Global Key Players of Crispr Genomic Cure, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Crispr Genomic Cure Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Crispr Genomic Cure Revenue Market Share by Type (2020-2025)
Table 26. Global Crispr Genomic Cure Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Crispr Genomic Cure Revenue Market Share by Type (2026-2031)
Table 28. Global Crispr Genomic Cure Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Crispr Genomic Cure Revenue Market Share by Application (2020-2025)
Table 30. Global Crispr Genomic Cure Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Crispr Genomic Cure Revenue Market Share by Application (2026-2031)
Table 32. North America Crispr Genomic Cure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Crispr Genomic Cure Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Crispr Genomic Cure Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Crispr Genomic Cure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Crispr Genomic Cure Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Crispr Genomic Cure Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Crispr Genomic Cure Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Crispr Genomic Cure Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Crispr Genomic Cure Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Crispr Genomic Cure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Crispr Genomic Cure Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Crispr Genomic Cure Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Crispr Genomic Cure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Crispr Genomic Cure Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Crispr Genomic Cure Market Size by Country (2026-2031) & (US$ Million)
Table 47. Abcam Company Details
Table 48. Abcam Business Overview
Table 49. Abcam Crispr Genomic Cure Product
Table 50. Abcam Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)
Table 51. Abcam Recent Development
Table 52. Applied StemCel Company Details
Table 53. Applied StemCel Business Overview
Table 54. Applied StemCel Crispr Genomic Cure Product
Table 55. Applied StemCel Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)
Table 56. Applied StemCel Recent Development
Table 57. Beam Therapeutics Company Details
Table 58. Beam Therapeutics Business Overview
Table 59. Beam Therapeutics Crispr Genomic Cure Product
Table 60. Beam Therapeutics Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)
Table 61. Beam Therapeutics Recent Development
Table 62. CALYXT Company Details
Table 63. CALYXT Business Overview
Table 64. CALYXT Crispr Genomic Cure Product
Table 65. CALYXT Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)
Table 66. CALYXT Recent Development
Table 67. Cellecta Company Details
Table 68. Cellecta Business Overview
Table 69. Cellecta Crispr Genomic Cure Product
Table 70. Cellecta Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)
Table 71. Cellecta Recent Development
Table 72. Cellectis Company Details
Table 73. Cellectis Business Overview
Table 74. Cellectis Crispr Genomic Cure Product
Table 75. Cellectis Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)
Table 76. Cellectis Recent Development
Table 77. CRISPR Therapeutics AG Company Details
Table 78. CRISPR Therapeutics AG Business Overview
Table 79. CRISPR Therapeutics AG Crispr Genomic Cure Product
Table 80. CRISPR Therapeutics AG Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)
Table 81. CRISPR Therapeutics AG Recent Development
Table 82. Editas Medicine Company Details
Table 83. Editas Medicine Business Overview
Table 84. Editas Medicine Crispr Genomic Cure Product
Table 85. Editas Medicine Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)
Table 86. Editas Medicine Recent Development
Table 87. ERS Genomics Company Details
Table 88. ERS Genomics Business Overview
Table 89. ERS Genomics Crispr Genomic Cure Product
Table 90. ERS Genomics Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)
Table 91. ERS Genomics Recent Development
Table 92. Integrated DNA Technologies Company Details
Table 93. Integrated DNA Technologies Business Overview
Table 94. Integrated DNA Technologies Crispr Genomic Cure Product
Table 95. Integrated DNA Technologies Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)
Table 96. Integrated DNA Technologies Recent Development
Table 97. Intellia Therapeutics Company Details
Table 98. Intellia Therapeutics Business Overview
Table 99. Intellia Therapeutics Crispr Genomic Cure Product
Table 100. Intellia Therapeutics Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)
Table 101. Intellia Therapeutics Recent Development
Table 102. Merck KGaA Company Details
Table 103. Merck KGaA Business Overview
Table 104. Merck KGaA Crispr Genomic Cure Product
Table 105. Merck KGaA Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)
Table 106. Merck KGaA Recent Development
Table 107. New England Biolabs Company Details
Table 108. New England Biolabs Business Overview
Table 109. New England Biolabs Crispr Genomic Cure Product
Table 110. New England Biolabs Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)
Table 111. New England Biolabs Recent Development
Table 112. Precision BioSciences Company Details
Table 113. Precision BioSciences Business Overview
Table 114. Precision BioSciences Crispr Genomic Cure Product
Table 115. Precision BioSciences Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)
Table 116. Precision BioSciences Recent Development
Table 117. Sangamo Therapeutics Company Details
Table 118. Sangamo Therapeutics Business Overview
Table 119. Sangamo Therapeutics Crispr Genomic Cure Product
Table 120. Sangamo Therapeutics Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)
Table 121. Sangamo Therapeutics Recent Development
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
Table 125. Authors List of This Report
List of Figures
Figure 1. Crispr Genomic Cure Picture
Figure 2. Global Crispr Genomic Cure Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Crispr Genomic Cure Market Share by Type: 2024 VS 2031
Figure 4. gRNA Design and Vector Construction Features
Figure 5. Cell Line and Engineering Features
Figure 6. Others Features
Figure 7. Global Crispr Genomic Cure Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Crispr Genomic Cure Market Share by Application: 2024 VS 2031
Figure 9. Biomedical Case Studies
Figure 10. Pharmaceutical Case Studies
Figure 11. Agricultural Case Studies
Figure 12. Others Case Studies
Figure 13. Crispr Genomic Cure Report Years Considered
Figure 14. Global Crispr Genomic Cure Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Crispr Genomic Cure Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Crispr Genomic Cure Market Share by Region: 2024 VS 2031
Figure 17. Global Crispr Genomic Cure Market Share by Players in 2024
Figure 18. Global Top Crispr Genomic Cure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crispr Genomic Cure as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Crispr Genomic Cure Revenue in 2024
Figure 20. North America Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Crispr Genomic Cure Market Share by Country (2020-2031)
Figure 22. United States Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Crispr Genomic Cure Market Share by Country (2020-2031)
Figure 26. Germany Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Crispr Genomic Cure Market Share by Region (2020-2031)
Figure 34. China Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Crispr Genomic Cure Market Share by Country (2020-2031)
Figure 42. Mexico Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Crispr Genomic Cure Market Share by Country (2020-2031)
Figure 46. Turkey Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Abcam Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)
Figure 50. Applied StemCel Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)
Figure 51. Beam Therapeutics Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)
Figure 52. CALYXT Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)
Figure 53. Cellecta Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)
Figure 54. Cellectis Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)
Figure 55. CRISPR Therapeutics AG Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)
Figure 56. Editas Medicine Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)
Figure 57. ERS Genomics Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)
Figure 58. Integrated DNA Technologies Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)
Figure 59. Intellia Therapeutics Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)
Figure 60. Merck KGaA Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)
Figure 61. New England Biolabs Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)
Figure 62. Precision BioSciences Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)
Figure 63. Sangamo Therapeutics Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
